Notably, the NCF-2 meta-locus implicates several GABA receptor genes, as well as the GABA transporter SLC6A1, suggesting the possibility that GABA-ergic treatment approaches may enhance NCF while simultaneously ameliorating the correlated affective and anxiety symptoms that load on this meta-locus. Here, SLC6A1 is linked to Anxiety.